CONFRONTING PICTURE OF GROWING WOMEN’S HEALTH CRISIS IN UTERINE CANCERS. ANZGOG State of the Nation report highlights inequities in uterine cancer outcomes across Australia
With
Associate Professor Yoland Antill, Director and Deputy Chair, Australia New Zealand Gynaecological Oncology Group (ANZGOG)
SEGMENT
Filmed in Melbourne | December 2025
Uterine cancers have become Australia’s fastest-growing women’s cancer, with incidence doubling over the past 25 years and projected to continue to surge. Without immediate action, more than 44,000 women are expected to be diagnosed by 2035, and 8,900 will lose their lives to the disease.
Released November 2025, Australia’s first State of the Nation: Uterine Cancers in Australia 2025 report by the Australia New Zealand Gynaecological Oncology Group (ANZGOG), reveals a confronting picture of a growing women’s health crisis that has gone largely unseen and one that now requires immediate, coordinated national action.
Once considered a cancer that primarily affected older women, the report highlights an alarming new trend: incidence is now rising fastest among women aged 25 to 44, with cases in this age group expected to increase by around 60 per cent alone, over the next decade.
Despite its growing impact, uterine cancer remains largely invisible in Australia’s cancer conversation. The limited research available notes, 94 per cent of women are unaware of what uterine or endometrial cancers are yet increased awareness of the disease and risk factors could prevent up to 60 per cent of future diagnoses. Research investment for uterine cancers lags far behind other cancers.
In addition, support and psychosocial care for women living with uterine cancers are inconsistent, and currently there is no dedicated national advocacy organisation. Many women face pain, fatigue, anxiety and long-term side effects alone.
State of the Nation report sets out a national plan to reverse the rise in uterine cancers and transform outcomes for Australian women
The report identifies five urgent priorities: halve incidence, eliminate inequities, ensure access to precision care, support every woman to live well, and invest in research and data. Achieving these goals will require united action from government, researchers, clinicians, industry and the community to deliver the innovation, equity and support Australian women deserve.
Source: Adapted from ANZGOG media release November 2025
Report: ANZGOG State of the Nation Report into Uterine Cancers can be read here https://www.anzgog.org.au/sotn-uterine-cancer, prepared by Insight Economics
-
Understanding factors of persistent lower back pain in women
Lizzy Quinn is a Musculoskeletal Physiotherapist with 20 years experience focusing on people with spinal pain. Australian Health Journal spoke with Lizzy on the complexities of persistent lower back pain in women.
Lower back pain in women in their 30s, 40s, and 50s is complex to treat due to the combination of physical and emotional factors, and health professionals need to stay updated on best practices and science to provide the best recovery platform for patients. These women typically have busy lives, pressures, and expectations.
-
Australian Teletrial Program reaches significant milestones in trials and participants
Launched in 2022, the Australian Teletrial Program is an initiative designed to improve access to clinical trials for people living in regional and remote areas of Australia. It uses telemedicine and digital technologies to enable patients to participate in clinical trials without needing to travel long distances to major metropolitan centres, which can often be a barrier to participation for those in rural and isolated locations.
Recently Australian Health Journal met with Kaye Hewson, Director, Australian Teletrials Program, who spoke about the program’s recent achievements.
-
Impact of genetic pathologist role across medicine
Dr Marina Berbic is a genetic pathologist and the Deputy Director of Genetics at Douglass Hanly Moir Pathology – a laboratory based in Sydney and part of Sonic Healthcare. The genetics department at Douglass Hanly Moir offers a wider array of genetic tests across many domains, and the medical leadership model ensures the highest possible standard of care and commitment to patient safety.
